Speaker illustration

Doctor Ryo Kurosawa

Tohoku University Graduate School of Medicine, Sendai (Japan)

Identification of celastramycin as a novel therapeutic agent for pulmonary arterial hypertension -high-throughput screening of 5,562 compounds-

Event: ESC CONGRESS 2019

Topic: Hypertension, Pulmonary Hypertension

Session: Novel pharmacological targets in vascular disease

Thumbnail

This platform is supported by

logo Novo Nordisk